4//SEC Filing
Taylor Daphne 4
Accession 0000950170-24-025921
CIK 0001671584other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:13 PM ET
Size
10.4 KB
Accession
0000950170-24-025921
Insider Transaction Report
Form 4
Taylor Daphne L
SVP, CFO
Transactions
- Exercise/Conversion
Common Stock
2024-03-02+3,667→ 16,827 total - Exercise/Conversion
Common Stock
2024-03-04+1,584→ 18,411 total - Exercise/Conversion
Restricted Stock Unit
2024-03-02−3,667→ 7,333 total→ Common Stock (3,667 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-03-04−1,584→ 1,583 total→ Common Stock (1,584 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On March 3, 2023, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
- [F3]On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001393549
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:13 PM ET
- Size
- 10.4 KB